Tebra wants the doctor to go home.

The appointment can be over while the work is still going. There is a note to finish, a claim to prepare, a prescription to send. That distinction, between finishing the visit and finishing the job, is where Tebra has planted its business. Its promise to independent practices is that connecting the surrounding work might give the clinician something surprisingly scarce: a stopping time.

The gap between the search and the chart

In November 2021, two businesses approached the same doctor from different directions. Kareo supplied clinical and financial software. PatientPop helped practices attract patients online. A prospective patient might encounter a PatientPop website before ever appearing in a Kareo record. The companies occupied different portions of one continuous experience.

What pushed them together was a customer request. In the merger announcement, PatientPop co-founder Luke Kervin explained that customers had been asking for deeper integration with their clinical and financial system of record. Marketing could fill the calendar. It could not, by itself, connect that calendar to everything behind the reception desk.

The merger made Kareo founder Dan Rodrigues CEO of Tebra. Kervin became chief innovation officer; fellow PatientPop co-founder Travis Schneider became chief corporate development officer. The name came from vertebrae. A backbone was an apt ambition for a company whose problem was getting separate pieces to support the same body.

A practice is also a small business

Follow the patient. First comes discovery: a website, a search result, a review. Then booking, reminders, and intake. During the visit come charting, prescriptions, and laboratory orders. Afterward come insurance claims, payment collection, and follow-up. Tebra sells tools across that sequence, including telehealth and a patient portal.

Its customers include independent physicians, nurse practitioners, therapists, small groups, and billing companies. A psychiatrist and a pediatrician have different encounters, but both need an appointment to become a usable record and a payment. Tebra’s expertise combines clinical administration, revenue collection, and the comparatively commercial business of getting found.

Alternatives include ambulatory platforms such as athenahealth, eClinicalWorks, AdvancedMD, and DrChrono, alongside specialty software and individual marketing or scribing tools. Tebra’s distinguishing proposition is the breadth of the connected practice workflow. A buyer should judge that connection against the particular specialty and existing systems, rather than assuming a longer feature list means a better fit.

The connections also extend beyond Tebra’s own tools. A November 2025 DrFirst partnership added RxInform prescription notifications, educational resources, and pickup reminders. A July partnership with WoundZoom addressed imaging and reporting for wound care. Both concern what happens after information is created: whether it reaches the person or workflow that needs to act on it. A prescription sitting in a chart and a prescription collected at a pharmacy are different milestones.

There is a revealing number in Tebra’s July 2022 financing announcement. Its businesses supported more than 100,000 providers, but only more than 800 were using the combined operating system. An installed customer base and adoption of a joined-up product were different things. The merger created the opportunity; integration still had to earn its place.

The evening is the product

AI Note Assist, launched in June 2025, makes the argument tangible. It listens during a visit and produces an editable clinical note inside the EHR. Supported formats include SOAP, therapy, and psychiatric notes. It can suggest diagnosis codes. The clinician reviews and approves the result.

A separate scribe can produce useful text. An embedded scribe also has a chance to remove the transfer into the chart. That is Tebra’s wager: automation becomes more useful when it sits where the next piece of work already happens.

“I got to go home early yesterday because of AI Note Assist.”

Jennifer Sigler · Beaumont WELLness for Women
Customer account published by Tebra

That customer remark describes the intended outcome more clearly than a feature inventory. Tebra has also published documentation-time reductions from its users. Those are company-reported results, not a timetable every practice can expect. The relevant question is what happens to the entire working day.

In December 2025, Tebra announced $250 million in equity and debt financing, with equity led by Hildred and a J.P. Morgan debt facility. Its stated priorities included documentation, revenue recovery, and practice growth. The financing announcement reported more than 140,000 providers. That figure describes platform reach, rather than universal adoption of every AI feature.

Count the whole bill

Tebra charges for software through provider subscriptions. Its published range runs from $49 to $799 per provider monthly across different solutions and bundles. The $49 entry point is a specific offering with conditions, not the price of the full system. Provider type, claim volume, implementation, and add-ons affect the bill.

AI Note Assist has a $0.99 per-note option or a $99 monthly subscription, with 400 notes included and $0.25 for each additional note. At 100 notes, those two options cost the same. The calculation below compares the AI charge alone; an underlying Tebra clinical subscription is still required.

A draft is still a draft

The help documentation supplies the useful friction. AI Note Assist is supported on desktop or laptop browsers, not mobile browsers or Tebra’s mobile app. It excludes group telehealth and third-party telehealth software. A practice built around those workflows cannot assume the scribe follows it everywhere.

More fundamentally, Tebra’s instructions for finalizing a generated note say providers must add applicable structured information, including vitals and medications. A fluent paragraph does not automatically finish the record. Review and completion remain part of the job.

There is a practical idea here that any practice can copy. Follow one appointment from discovery to collection. Count the occasions when someone retypes information or carries it between systems. Then trial one change and measure time to a signed note or a resolved claim, including corrections. Tebra’s case becomes persuasive when the last task ends earlier. That is when the doctor can actually leave.